Fig. 1From: ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE studyDistribution of patients according to the number of severe exacerbations experienced in the 12 months prior to the index date. Evaluable patients with information on previous exacerbations were 196Back to article page